title: Detection and quantitation of β-blockers in plasma and urine.
abstract: β-blockers are a class of antihypertensive drugs that are used for the management of cardiac arrhythmias, cardioprotection after myocardial infarction (heart attack) and hypertension. They have revolutionized the medical management of angina pectoris and are recommended as first-line agents by national and international guidelines. Although β-blockers are still the cornerstone for the treatment of heart failure, some of the drugs in this category are prohibited in several sports requiring vehicle control and bodily movements as they reduce heart rate and tremors, and improve performance. As a result, urine analysis of β-blockers is mandatory in doping control and toxicological screening. The determination of plasma levels of β-blockers helps to ensure noncompliance in patients with persistent hypertonia to confirm the diagnosis of β-blocker poisoning and for therapeutic drug monitoring. This review provides a comprehensive account of various analytical methods developed for detection and quantitation of β-blockers in plasma and urine.
authors.affiliation: Chemistry Department, School of Sciences, Gujarat University, Navrangpura, Ahmedabad-380009. pranav_shrivastav@yahoo.com
authors.forename: Pranav S
authors.initials: PS
authors.lastname: Shrivastav
authors.forename: Shailesh M
authors.initials: SM
authors.lastname: Buha
authors.forename: Mallika
authors.initials: M
authors.lastname: Sanyal
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000097:blood* / Q000145:classification / Q000302:isolation & purification / Q000652:urine*; D053000:Analytic Sample Preparation Methods; D000818:Animals; D001774:Blood Chemical Analysis / Q000379:methods*; D006801:Humans; D011943:Receptors, Adrenergic, beta / Q000378:metabolism; D016482:Urinalysis / Q000379:methods*
chemical_list: D000319:Adrenergic beta-Antagonists; D011943:Receptors, Adrenergic, beta